Referencias Bibliográficas

1) L. Chávez-Teyes, G. Castañeda-Hernández and F.J. Flores-Murrieta. Pharmacokinetics of midazolam in Mexicans: Evidence for interethnic variability. Clin. Drug Invest. 17: 233-239, 1999.

2) F.J. Flores-Murrieta,G. Castañeda-Hernàndez, V. Granados-Soto, J.E. Herrera. Increased bioavailability of sildenafil in Mexican men. JAMA 283: 1825-1826, 2000.

3) M. Josa, J. Pérez-Urizar, J. Rapado, C. Dios-Viéitez, G. Castañeda-Hernández, F. Flores-Murrieta, M.J. Renedo, I. Trocóniz. Pharmacokinetic-pharmacodynamic modelling of antipyretic and anti-inflammatory effects of naproxen in the rat. J. Pharmacol. Exp. Ther. 297: 198-205, 2001.

4) J. Pérez-Urizar, V. Granados-Soto, G. Castañeda-Hernández, E. Hong, C. González, J.L. Martínez, F.J. Flores-Murrieta. Analgesic efficacy and bioavailability of ketorolac in postoperative pain: A probability analysis. Arch. Med. Res. 31: 191-196, 2000.

5) J. Pérez-Urizar, V. Granados-Soto, F.J. Flores-Murrieta, G. Castañeda-Hernández. Pharmacokinetic-pharmacodynamic modelling, why? Arch. Med. Res. 31: 539-545, 2000.

6) L. Cruz, G. Castañeda-Hernández, F.J. Flores-Murrieta, P. García-López, G. Guisar-Sahagún. Alteration of Phenacetin pharmacokinetics after experimental spinal cord injury. Proc. West. Pharmacol. Soc. 45: 4-5, 2002.

7) J. Pérez-Urizar, F.J. Flores-Murrieta, G. Castañeda-Hernández. Effect of experimental hypoalbuminemia on the plasma protein binding of tolmetin. Life Sci. 71: 1015-1022, 2002.

8) J. Pérez-Urizar, M.E. Aguilar-Cota, J.E. Herrera, F.J. Flores-Murrieta. Comparative bioavailability of ketorolac tromethamiine after intramuscular and sublingual administration. Proc. West. Pharmacol. Soc. 45: 6-7, 2002.

9) M.C. Carrasco-Portugal, M.E. Aguilar-Cota, J. Pérez-Urizar, O. Cabrera, J.E. Herrera, F.J. Flores-Murrieta. Bioavailability of a formulation containing a Diclofenac-Ranitidine combination. Proc. West. Pharmacol. Soc. 45: 8-10, 2002.

10) H. León-Molina, F.J. Flores-Murrieta, R. Chapela. Assessment of comparative bioequivalence of two metered-dose inhaler formulations of Salbutamol measuring bronchodilatory effect in patients with asthma. Clin Drug Invest 22: 435-441, 2002.